Latest Lung Cancer News | NSCLC/SCLC Treatment Information

Lung Cancers News

LUNG CANCER ADVISOR

Lung Cancers News

FDA_drug approval

Zepzelca Approved for Metastatic Small Cell Lung Cancer

The FDA has approved Zepzelca™ (lurbinectedin; Jazz Pharmaceuticals) for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
Next post in Lung Cancer News